Smith & Nephew slashes guidance as China slowdown continues
Thursday, 31 October 2024
Hip and knee implant maker Smith & Nephew has cut its full-year guidance as it continues to grapple with a slowdown in China. It booked third quarter revenue of $1.4bn (£1.08bn), up four per cent year on year, but Chinese sales dragged as the region experienced “worse than expected headwinds” across the surgical businesses. The [...]
|
||||
|
|
||||
You Might Like |
||||
